JP2015526385A - てんかんの治療のための組成物及び方法 - Google Patents

てんかんの治療のための組成物及び方法 Download PDF

Info

Publication number
JP2015526385A
JP2015526385A JP2015510893A JP2015510893A JP2015526385A JP 2015526385 A JP2015526385 A JP 2015526385A JP 2015510893 A JP2015510893 A JP 2015510893A JP 2015510893 A JP2015510893 A JP 2015510893A JP 2015526385 A JP2015526385 A JP 2015526385A
Authority
JP
Japan
Prior art keywords
compound
disorder
administration
formula
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015510893A
Other languages
English (en)
Japanese (ja)
Inventor
カンデュラ,マヘシュ
Original Assignee
セリックスビオ プライヴェート リミテッド
セリックスビオ プライヴェート リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セリックスビオ プライヴェート リミテッド, セリックスビオ プライヴェート リミテッド filed Critical セリックスビオ プライヴェート リミテッド
Publication of JP2015526385A publication Critical patent/JP2015526385A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2015510893A 2012-05-08 2013-01-29 てんかんの治療のための組成物及び方法 Pending JP2015526385A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1791/CHE/2012 2012-05-08
IN1791CH2012 2012-05-08
PCT/IB2013/050740 WO2013167986A2 (fr) 2012-05-08 2013-01-29 Compositions et méthodes de traitement de l'épilepsie

Publications (1)

Publication Number Publication Date
JP2015526385A true JP2015526385A (ja) 2015-09-10

Family

ID=54187089

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015510893A Pending JP2015526385A (ja) 2012-05-08 2013-01-29 てんかんの治療のための組成物及び方法

Country Status (7)

Country Link
EP (1) EP2846795A2 (fr)
JP (1) JP2015526385A (fr)
AU (1) AU2013257707A1 (fr)
CA (1) CA2873016A1 (fr)
SG (1) SG11201407309XA (fr)
WO (1) WO2013167986A2 (fr)
ZA (1) ZA201408058B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015519334A (ja) * 2012-05-07 2015-07-09 セリックスビオ プライヴェート リミテッド 抗血小板薬のプロドラッグ
JP2015527309A (ja) * 2012-07-03 2015-09-17 セリックスビオ プライヴェート リミテッド 中等度から重度の疼痛の治療のための組成物及び方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170048313A (ko) * 2014-06-02 2017-05-08 케토젠 인코포레이티드 발작 및 기타 중추신경계 장애 및 병증 치료용 화합물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ292256B6 (cs) * 1995-05-05 2003-08-13 Novo Nordisk A/S Farmaceutická směs a způsob její přípravy
WO2006062980A2 (fr) * 2004-12-07 2006-06-15 Nektar Therapeutics Formulation non cristalline stable comprenant de la tiagabine
US8338621B2 (en) * 2005-12-21 2012-12-25 Ucb S.A. Process for the preparation of 2-oxo-1-pyrrolidine derivatives
US8785661B2 (en) * 2009-05-13 2014-07-22 Nektar Therapeutics Oligome-containing pyrrolidine compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015519334A (ja) * 2012-05-07 2015-07-09 セリックスビオ プライヴェート リミテッド 抗血小板薬のプロドラッグ
JP2015527309A (ja) * 2012-07-03 2015-09-17 セリックスビオ プライヴェート リミテッド 中等度から重度の疼痛の治療のための組成物及び方法

Also Published As

Publication number Publication date
WO2013167986A2 (fr) 2013-11-14
CA2873016A1 (fr) 2013-11-14
ZA201408058B (en) 2016-03-30
AU2013257707A1 (en) 2014-11-27
SG11201407309XA (en) 2014-12-30
EP2846795A2 (fr) 2015-03-18
WO2013167986A3 (fr) 2015-06-18

Similar Documents

Publication Publication Date Title
JP6202287B2 (ja) 炎症性腸疾患の治療のための組成物及び方法
JP6698643B2 (ja) 多発性硬化症の治療のための組成物及び方法
JP2015518855A5 (fr)
JP2015518855A (ja) 粘膜炎の治療のための組成物および方法
JP2015520748A (ja) 炭酸脱水酵素活性の抑制のための組成物及び方法
WO2014115098A1 (fr) Compositions et procédés pour le traitement de maladies neurologiques et d'une inflammation
JP2016508956A (ja) 局所疼痛の治療のための組成物と治療法
WO2014068463A2 (fr) Compositions et procédés de traitement d'une inflammation et de troubles métaboliques
WO2014091384A2 (fr) Compositions et méthodes pour le traitement de la mucosite
JP2015518854A5 (fr)
JP2015518854A (ja) 多発性硬化症の治療のための組成物および方法
JP2015526385A (ja) てんかんの治療のための組成物及び方法
JP2015527309A (ja) 中等度から重度の疼痛の治療のための組成物及び方法
US9738631B2 (en) Compositions and methods for the treatment of neurological disorders
JP2015519333A5 (fr)
JP2015533114A (ja) 神経疾患の治療のための組成物及び方法
RU2751770C2 (ru) Композиции и способы лечения синдрома раздраженного кишечника
RU2749188C2 (ru) Композиции и способы лечения желудочно-кишечных полипов
JP2015519334A5 (fr)
WO2013167984A2 (fr) Compositions et méthodes de traitement de la douleur musculaire
JP2015519334A (ja) 抗血小板薬のプロドラッグ
WO2014057439A2 (fr) Compositions et procédés de traitement de maladies neurologiques et des complications associées
US20150087670A1 (en) Compositions and methods for the treatment of respiratory disorders
JP2015529218A (ja) 炎症と脂質障害の治療のための組成物及び方法
US9290486B1 (en) Compositions and methods for the treatment of epilepsy